MX2021013428A - Insertos oculares polimericos disolubles y metodo de uso de los mismos. - Google Patents

Insertos oculares polimericos disolubles y metodo de uso de los mismos.

Info

Publication number
MX2021013428A
MX2021013428A MX2021013428A MX2021013428A MX2021013428A MX 2021013428 A MX2021013428 A MX 2021013428A MX 2021013428 A MX2021013428 A MX 2021013428A MX 2021013428 A MX2021013428 A MX 2021013428A MX 2021013428 A MX2021013428 A MX 2021013428A
Authority
MX
Mexico
Prior art keywords
inserts
eye
ocular surface
eye inserts
dissolvable
Prior art date
Application number
MX2021013428A
Other languages
English (en)
Spanish (es)
Inventor
Walter R Laredo
Rekha Rangarajan
Howard Allen Ketelson
Stephen John Collins
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MX2021013428A publication Critical patent/MX2021013428A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2021013428A 2019-05-02 2020-05-01 Insertos oculares polimericos disolubles y metodo de uso de los mismos. MX2021013428A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962841901P 2019-05-02 2019-05-02
US201962927885P 2019-10-30 2019-10-30
PCT/IB2020/054148 WO2020222195A1 (en) 2019-05-02 2020-05-01 Dissolvable polymeric eye inserts and method of using same

Publications (1)

Publication Number Publication Date
MX2021013428A true MX2021013428A (es) 2021-12-10

Family

ID=70554143

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021013428A MX2021013428A (es) 2019-05-02 2020-05-01 Insertos oculares polimericos disolubles y metodo de uso de los mismos.

Country Status (12)

Country Link
US (1) US12102559B2 (cg-RX-API-DMAC7.html)
EP (1) EP3962450A1 (cg-RX-API-DMAC7.html)
JP (1) JP7350885B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220004969A (cg-RX-API-DMAC7.html)
CN (1) CN113795242B (cg-RX-API-DMAC7.html)
AU (1) AU2020266339B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021019774A2 (cg-RX-API-DMAC7.html)
CA (1) CA3137417C (cg-RX-API-DMAC7.html)
MX (1) MX2021013428A (cg-RX-API-DMAC7.html)
SG (1) SG11202110514RA (cg-RX-API-DMAC7.html)
TW (1) TWI826685B (cg-RX-API-DMAC7.html)
WO (1) WO2020222195A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017062770A1 (en) 2015-10-08 2017-04-13 Silverberg Noah Punctal plug and bioadhesives
US12491263B2 (en) 2019-05-13 2025-12-09 University of Pittsburgh—of the Commonwealth System of Higher Education Polymer-based implant for retinal therapy and methods of making and using the same
CN115066232B (zh) 2020-02-06 2024-12-10 视尔普斯眼科公司 用于治疗眼病的组合物和方法
EP4142664A4 (en) 2020-04-27 2024-05-29 Ocular Therapeutix, Inc. METHODS FOR TREATING ALLERGIC CONJUNCTIVITIS
EP4432990A4 (en) * 2021-11-16 2025-07-30 Univ Pittsburgh Commonwealth Sys Higher Education POLYMER-BASED GEL IMPLANT FOR RETINAL THERAPY AND METHODS OF MAKING AND USING THE SAME
WO2023119231A1 (en) * 2021-12-23 2023-06-29 Alcon Inc. Dissolvable medical device and kit for corneal surface protection
WO2023119235A1 (en) * 2021-12-23 2023-06-29 Alcon Inc. Dissolvable medical device for promoting healing of wounds
TW202339703A (zh) * 2021-12-23 2023-10-16 瑞士商愛爾康公司 用於藥物遞送的可溶解醫療裝置
WO2023214027A1 (en) * 2022-05-06 2023-11-09 Eyed Pharma Insert for the treatment of dry eyes
US20240207174A1 (en) * 2022-12-23 2024-06-27 Alcon Inc. Dissolvable polymeric eye inserts
WO2024180472A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Ocular inserts
WO2024180453A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Dissolvable polymeric eye inserts with a non-ionic cellulose derivative

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT75625B (en) 1981-10-08 1985-12-09 Merck & Co Inc Process for preparing biosoluble ocular insert
US4730013A (en) * 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert
ATE240698T1 (de) 1995-06-07 2003-06-15 Keravision Inc Radiales intrastromales hornhautimplantat
CA2602525A1 (en) 2005-03-21 2006-09-28 Macusight, Inc. Drug delivery systems for treatment of diseases or conditions
EP1973421A2 (en) * 2005-12-23 2008-10-01 Cadbury Adams USA LLC Compositions providing a sensation substantially similar to that provided by menthol
KR101555291B1 (ko) 2007-02-09 2015-09-30 알콘, 인코퍼레이티드 세가지 폴리머의 상승성 배합물을 함유하는 안과 조성물
US20130244978A1 (en) * 2007-09-14 2013-09-19 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
US20130172357A1 (en) * 2011-02-03 2013-07-04 Eye Therapies Llc Compositions and Methods for Treatment of Glaucoma
US20120215184A1 (en) 2011-02-18 2012-08-23 Valeant International (Barbados) Srl Cylindrical ocular inserts
US20140107025A1 (en) 2012-04-16 2014-04-17 Jade Therapeutics, Llc Ocular drug delivery system
UA113434C2 (uk) 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
RU2683651C2 (ru) 2013-06-18 2019-04-01 Иван Дмитриевич Захаров Лекарственное средство для лечения кератоконуса и других дегенеративных заболеваний роговицы и фармацевтические препараты на его основе
US9782345B2 (en) 2013-10-17 2017-10-10 Jade Therapeutics, Inc. Ocular composition and method
CA2947274C (en) * 2014-04-28 2019-03-19 Hampton Technologies Ophthalmic compositions and methods for treating eyes
JP6200108B2 (ja) 2014-06-20 2017-09-20 クーパーヴィジョン インターナショナル ホウルディング カンパニー リミテッド パートナーシップ 眼感染症の治療のための眼科用組成物
US9931306B2 (en) 2014-09-06 2018-04-03 Integral Biosystems Llc Methods and biocompatible compositions to achieve sustained drug release in the eye

Also Published As

Publication number Publication date
CA3137417A1 (en) 2020-11-05
WO2020222195A1 (en) 2020-11-05
TW202106286A (zh) 2021-02-16
US20200345544A1 (en) 2020-11-05
JP7350885B2 (ja) 2023-09-26
AU2020266339B2 (en) 2023-12-07
JP2022530758A (ja) 2022-07-01
AU2020266339A1 (en) 2021-12-23
CN113795242B (zh) 2026-06-16
KR20220004969A (ko) 2022-01-12
TWI826685B (zh) 2023-12-21
US12102559B2 (en) 2024-10-01
EP3962450A1 (en) 2022-03-09
CA3137417C (en) 2024-01-09
CN113795242A (zh) 2021-12-14
BR112021019774A2 (pt) 2021-12-07
SG11202110514RA (en) 2021-11-29

Similar Documents

Publication Publication Date Title
BR112021019774A2 (pt) Insertos oculares poliméricos dissolvíveis e método para usar os mesmos
TW200605915A (en) Drug delivery compositions
WO2006031658A3 (en) Therapeutic lacrimal canalicular inserts and related methods
BRPI0506983A (pt) composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
MX2020011301A (es) Uso de clorhidrato de pilocarpina para el tratamiento de afecciones oculares.
TW200603775A (en) Anti-excitotoxic sustained release intraocular implants and related methods
WO2011130462A3 (en) Intraocular pressure reduction with intracameral bimatoprost implants
WO2013030679A3 (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
WO2016172712A3 (en) Ophthalmic composition
HK1223271A1 (zh) 眼部装置
WO2017158366A3 (en) Ophthalmic delivery device and ophthalmic drug compositions
EA201300272A1 (ru) Применение фотоусиливающих агентов в ассоциации с рибофлавином, а также соответствующих офтальмологических композиций для перекрестного сшивания роговицы при лечении кератоконуса или других эктазийных расстройств роговицы
WO2006088650A3 (en) Method of treating eye injury with local administration of a vegf inhibitor
HK1205461A1 (zh) 用於眼部传输治疗剂的组合物和方法
WO2005110367A3 (en) Sustained release intraocular implants and methods for preventing retinal dysfunction
WO2008060359A3 (en) Biodegradable ocular implants and methods for treating ocular conditions
MX2019004468A (es) Uso de lentes de contacto en el tratamiento de una afeccion oftalmologica.
TW200616643A (en) Ophthalmic compositions and methods for treating ophthalmic conditions
TW201613588A (en) Ophthalmic composition
WO2010056598A3 (en) Biodegradable alpha-2 adrenergic agonist polymeric implants
SG10201809363SA (en) Methods of treatment of ocular conditions with a sustained drug delivery implant
WO2007038687A3 (en) Ocular administration of immunosuppressive agents
WO2004066979A3 (en) Sustained release device and method for ocular delivery of adrenergic agents
JP2011518842A5 (cg-RX-API-DMAC7.html)
MX2020006309A (es) Fórmulaciones de parasiticida de isoxazolina y métodos para el tratamiento de la blefaritis.